MORONI, ELISABETTA MARIA
 Distribuzione geografica
Continente #
AS - Asia 1.443
NA - Nord America 791
EU - Europa 441
SA - Sud America 292
AF - Africa 25
OC - Oceania 2
Totale 2.994
Nazione #
US - Stati Uniti d'America 752
SG - Singapore 623
CN - Cina 298
BR - Brasile 235
IT - Italia 188
HK - Hong Kong 172
VN - Vietnam 145
FR - Francia 79
KR - Corea 53
FI - Finlandia 37
IN - India 36
NL - Olanda 31
DE - Germania 29
AR - Argentina 28
JP - Giappone 27
GB - Regno Unito 19
BD - Bangladesh 18
MX - Messico 14
CA - Canada 11
ZA - Sudafrica 11
ID - Indonesia 9
IL - Israele 9
CO - Colombia 8
IQ - Iraq 7
PK - Pakistan 6
PL - Polonia 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
EC - Ecuador 5
ES - Italia 5
IE - Irlanda 5
PE - Perù 5
TR - Turchia 5
AL - Albania 4
CL - Cile 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
UA - Ucraina 4
UZ - Uzbekistan 4
BB - Barbados 3
BE - Belgio 3
EG - Egitto 3
JM - Giamaica 3
NP - Nepal 3
PY - Paraguay 3
SE - Svezia 3
TN - Tunisia 3
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
KE - Kenya 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
MY - Malesia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
SK - Slovacchia (Repubblica Slovacca) 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
GR - Grecia 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MF - Saint Martin 1
MK - Macedonia 1
MN - Mongolia 1
MT - Malta 1
NI - Nicaragua 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
UY - Uruguay 1
VE - Venezuela 1
Totale 2.994
Città #
Singapore 358
Santa Clara 312
Hong Kong 170
Hefei 130
Ashburn 77
San Jose 76
Lauterbourg 65
Milan 61
Beijing 55
Seoul 53
Ho Chi Minh City 48
Los Angeles 48
Hanoi 34
Dallas 32
Lappeenranta 23
São Paulo 16
Tokyo 15
Brescia 14
Mumbai 12
Rio de Janeiro 11
Alzano Lombardo 10
Johannesburg 10
New York 10
Da Nang 9
Frankfurt am Main 9
Minamishinagawa 8
Nuremberg 8
Council Bluffs 7
Helsinki 7
Montreal 7
Padova 7
Trieste 7
Turku 7
Buffalo 6
Florence 6
Belo Horizonte 5
Bengaluru 5
Campinas 5
Chennai 5
Curitiba 5
Warsaw 5
Amsterdam 4
Brasília 4
Brooklyn 4
Buenos Aires 4
Chicago 4
Cirimido 4
Colombo 4
Falkenstein 4
Guangzhou 4
Guarulhos 4
Haiphong 4
Houston 4
Hải Dương 4
Lima 4
London 4
Mexico City 4
Pelotas 4
Porto Alegre 4
Tashkent 4
Atlanta 3
Bergamo 3
Biên Hòa 3
Bologna 3
Bridgetown 3
Brussels 3
Denver 3
Dhaka 3
Dublin 3
Manaus 3
Ninh Bình 3
Orem 3
Osaka 3
Quito 3
Quận Một 3
Riyadh 3
San Francisco 3
Scandicci 3
Shenzhen 3
Sorrento 3
Vienna 3
Addis Ababa 2
Agawam 2
Aracaju 2
Arese 2
Baghdad 2
Blumenau 2
Bogotá 2
Boston 2
Bắc Giang 2
Cairo 2
Can Tho 2
Canoas 2
Caxias do Sul 2
Ciudad del Este 2
Daytona Beach 2
Düsseldorf 2
Elk Grove Village 2
Florianópolis 2
Fortaleza 2
Totale 1.935
Nome #
Design and Test of Molecules that Interfere with the Recognition Mechanisms between the SARS-CoV-2 Spike Protein and Its Host Cell Receptors 108
Point mutations of the mitochondrial chaperone TRAP1 affect its functions and pro-neoplastic activity 83
Frontiers and Challenges of Computing ncRNAs Biogenesis, Function and Modulation 81
Conformational Dynamics of hAgo2 Silencing: Decoding Functional Divergence across Human Argonaute Paralogs 78
Target oriented-drug discovery: unraveling the molecular interaction between Leishmania Hsp90 and a celastrol carboxamide derivative 71
The Answer Lies in the Energy: How Simple Atomistic Molecular Dynamics Simulations May Hold the Key to Epitope Prediction on the Fully Glycosylated SARS-CoV-2 Spike Protein 68
Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design 66
Design of allosteric stimulators of the HSP90 ATPase as novel anticancer leads 63
Visualizing the Dynamics of a Protein Folding Machinery: The Mechanism of Asymmetric ATP Processing in Hsp90 and its Implications for Client Remodelling 62
N-Glycosylation-Induced Pathologic Protein Conformations as a Tool to Guide the Selection of Biologically Active Small Molecules 61
Machine Learning of Allosteric Effects: The Analysis of Ligand-Induced Dynamics to Predict Functional Effects in TRAP1 60
Insights from molecular dynamics simulations for the development of modulators of mitochondrial Hsp90 (Trap1) activity 59
Integrating Protein Interaction Surface Prediction with a Fragment-Based Drug Design: Automatic Design of New Leads with Fragments on Energy Surfaces 58
HIF1alfa-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia 57
How aberrant N-glycosylation can alter protein functionality and ligand binding: An atomistic view 57
Editorial: Computational drug discovery for targeting of protein-protein interfaces—Volume II 55
Transcription factor protein interactomes reveal genetic determinants in heart disease 53
Honokiol Bis-Dichloroacetate Is a Selective Allosteric Inhibitor of the Mitochondrial Chaperone TRAP1 52
Design and synthesis of cyclic peptides targeting Gas6 50
Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1 49
N-Glycosylation as a Modulator of Protein Conformation and Assembly in Disease 48
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 47
Investigating Dynamic and Energetic Determinants of Protein Nucleic Acid Recognition: Analysis of the Zinc Finger Zif268-DNA Complexes 45
Allosteric Regulation Points Control the Conformational Dynamics of the Molecular Chaperone Hsp90 45
Protein Allostery and Ligand Design: Computational Design Meets Experiments to Discover Novel Chemical Probes 43
Atomistic Simulations of the Mechanisms of the Poorly Catalytic Mitochondrial Chaperone Trap1: Insights into the Effects of Structural Asymmetry on Reactivity 43
Conformational Behavior of SARS-Cov-2 Spike Protein Variants: Evolutionary Jumps in Sequence Reverberate in Structural Dynamic Differences 42
Studying the Dynamics of a Complex G-Quadruplex System: Insights into the Comparison of MD and NMR Data 42
Advancing Molecular Simulations: Merging Physical Models, Experiments, and AI to Tackle Multiscale Complexity 40
The Dynamics of the Folding Machinery 40
Expedient Access to 2-Benzazepines by Palladium-Catalyzed C-H Activation: Identification of a Unique Hsp90 Inhibitor Scaffold 38
Disulfide-mediated tetramerization of TRAP1 fosters its antioxidant and pro-neoplastic activities 38
Machine Learning Prediction of Allosteric Drug Activity from Molecular Dynamics 38
A Fe2+-dependent self-inhibited state influences the druggability of human collagen lysyl hydroxylase (LH/PLOD) enzymes 38
Arrestins as Possible Drug Targets 37
molecular dynamics simulations reveal the mechanisms of allosteric activation of Hsp90 by designed ligands 37
Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization. 37
Structural determinants of cold activity and glucose tolerance of a family 1 glycoside hydrolase (GH1) from Antarctic Marinomonas sp. ef1 36
A NMR and computational study of Smac mimics targeting both the BIR2 and BIR3 domains in XIAP protein 35
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 34
Evaluation of docking procedures reliability in affitins-partners interactions 34
Targeting the mitochondrial chaperone TRAP1: strategies and therapeutic perspectives 34
SARS-CoV-2 Spike Protein Mutations and Escape from Antibodies: A Computational Model of Epitope Loss in Variants of Concern 34
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 33
Molecular structure and enzymatic mechanism of the human collagen hydroxylysine galactosyltransferase GLT25D1/COLGALT1 33
Novel PARP-1 Inhibitor scaffolds disclosed by a dynamic structure-based pharmacophore approach 32
Cracking the chaperone code through the computational microscope 32
Exploiting conformational dynamics in drug discovery: Design of C-terminal inhibitors of Hsp90 with improved activities 31
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 31
The Structural Asymmetry of Mitochondrial Hsp90 (Trap1) Determines Fine Tuning of Functional Dynamics 31
MM/PBSA analysis of molecular dynamics simulations of bovine beta-lactoglobulin: free energy gradients in conformational transitions? 30
Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography 29
Dynamic-based discovery of new allosteric ligands targeting the Hsp90 C-terminal inhibitor binding site 29
Identification of DNA-binding protein target sequences by physical effective energy functions: Free energy analysis of lambda repressor-DNA complexes 29
The Dynamics of Drug Discovery 29
Structures, dynamics, complexes, and functions: From classic computation to artificial intelligence 29
Computational approaches meet experiments to design new allosteric ligands 28
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 28
Molecular dynamics simulations of hsp90 with an eye to inhibitor design. 27
Investigating dynamic and energetic determinants of protein nucleic acid recognition: Analysis of the zinc finger zif268-DNA complexes 27
Long-Pentraxin 3 Derivative as a Small-Molecule FGF Trap for Cancer Therapy 27
Rational design, synthesis and characterization of potent, non-peptidic Smac mimics/XIAP inhibitors as proapoptotic agents for cancer therapy 27
Conformational regulation of Hsp90 through mutation and small molecules 27
A Molecular Dynamics Study of the Interaction of D-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation 27
Using QM/MM Molecular Dynamics to Model Reactivity in the mitochondrial Chaperone Trap1 26
Conformational regulation of Hsp90 though mutations and small molecules 26
Chemical and Biophysical Approaches to Allosteric Modulation 26
Impact of Mutations on NPAC Structural Dynamics: Mechanistic Insights from MD Simulations 25
Second generation of fucose-based DC-SIGN ligands: Affinity improvement and specificity versus Langerin 25
Assessment of Mutational Effects on Peptide Stability through Confinement Simulations 25
Design, synthesis and biological evaluation of biphenylamide derivatives as Hsp90 C-terminal inhibitors 25
3D-QSAR-Assisted Design, Synthesis, and Evaluation of Novobiocin Analogues 24
Synthesis of Functionalized 2-(4-Hydroxyphenyl)-3-methylbenzofuran Allosteric Modulators of Hsp90 Activity 24
Identification of a new scaffold for Hsp90 C-terminal inhibition 24
Modifying Hsp90 dynamics and functional relationships through rationally designed allosteric activators 22
Structure and sequence determinants of aggregation investigated with molecular dynamics 21
Activation of Hsp90 activity and conformational dynamics through computationally designed allosteric ligands: functional implications 21
Structure and sequence determinants of aggregation investigated with molecular dynamics 19
Investigating allostery with atomistic biomolecular simulations 14
Totale 3.159
Categoria #
all - tutte 10.325
article - articoli 8.991
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 29
Totale 19.345


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202413 0 0 0 0 0 0 0 0 1 2 0 10
2024/20251.405 2 3 70 54 250 201 43 117 31 66 298 270
2025/20261.741 108 172 196 290 328 62 290 75 57 97 66 0
Totale 3.159